TheNote.app
STAT | Reporting from the frontiers of health and medicine

STAT+: Small biotech Abivax scores major win with ulcerative colitis trials

An experimental oral treatment from Abivax helped ease symptoms in patients with ulcerative colitis, a major win for the small Paris-based company.
favicon
statnews.com
statnews.com
Image for the article: STAT+: Small biotech Abivax scores major win with ulcerative colitis trials
RSS Hunter
© 2015-2025, TheNote.app
· Privacy Policy · Terms & Conditions · Contact · Android iOS MacOS